Transforming growth factor-beta inhibitor is a candidate drug for immunotherapy of oral squamous cell carcinoma
Transforming growth factor-beta inhibitor is a candidate drug for immunotherapy of oral squamous cell carcinoma
复制标题
转化生长因子-β抑制剂是口腔鳞癌免疫治疗的候选药物
DOI:
--
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Susumu Suzuki
中科院分区:
文献类型:
--
作者:
Yutaro Kondo;Taishi Takahara;Shoya Ono;Mitsuo Goto;Tetsuya Ogawa;Hideaki Ito;Akira Sato;Toyonori Tsuzuki;Kazuhiro Yoshikawa;Ryuzo Ueda;Susumu Suzuki